A multicenter review of deep venous thrombosis prophylaxis practice patterns for blunt hepatic trauma by Datta, Indraneel et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Journal of Trauma Management & 
Outcomes
Open Access Short Report
A multicenter review of deep venous thrombosis prophylaxis 
practice patterns for blunt hepatic trauma
Indraneel Datta1, Chad G Ball*1, Lucas R Rudmik1, Damian Paton-Gay2, 
Deepak Bhayana3, Peter Salat4, Colin Schieman1, Dean F Smith3, 
Mary vanWijngaarden-Stephens2 and John B Kortbeek1
Address: 1Department of Surgery, University of Calgary, Calgary, Canada, 2Department of Surgery, University of Alberta, Edmonton, Canada, 
3Department of Radiology, University of Calgary, Calgary, Canada and 4Department of Radiology, University of Alberta, Edmonton, Canada
Email: Indraneel Datta - idatta@ucalgary.ca; Chad G Ball* - ball.chad@gmail.com; Lucas R Rudmik - luke.rudmik@albertahealthservices.ca; 
Damian Paton-Gay - patongay@ualberta.ca; Deepak Bhayana - deepak.bhayana@albertahealthservices.ca; 
Peter Salat - peter.salat@calgaryhealthregion.ca; Colin Schieman - colin.schieman@gmail.com; 
Dean F Smith - dean.smith@calgaryhealthregion.ca; Mary vanWijngaarden-Stephens - mary.stephans@albertahealthservices.ca; 
John B Kortbeek - john.kortbeek@albertahealthservices.ca
* Corresponding author    
Abstract
Background: Non-operative management of blunt hepatic trauma is successful in the majority of
hemodynamically stable patients. Due to the risk of recurrent hemorrhage, pharmacologic deep
venous thrombosis (DVT) prophylaxis is often delayed. The optimal timing of prophylaxis is
unclear. A multi-centre, retrospective review of patients with blunt hepatic injuries presenting
between 2000 and 2004 was performed. All patients had an ISS ≥ 12 and a CT scan confirming
hepatic trauma. Patients were categorized into: (1) early DVT prophylaxis (≤ 48 hrs of admission),
(2) delayed prophylaxis (>48 hrs), and (3) no prophylaxis.
Methods and results: Thirty-seven (25%) and 45 (42%) patients received early and delayed DVT
prophylaxis respectively. The remainder (32%) received none. Mean hepatic injury grades were
lower in the early prophylaxis group (II) compared to the delayed and no prophylaxis cohorts (III)(p
= 0.002). The number of patients requiring post-admission blood transfusions was highest in the
delayed group (44%) compared to the early (26%) and no prophylaxis (6%) groups (p = 0.03). No
patient in the early prophylaxis cohort developed a DVT or required delayed angiographic or
operative intervention. Two patients in the delayed group failed non-operative management. Eight
(18%) patients in the delayed group developed a clinically significant DVT; 1 (2%) progressed to a
PE.
Conclusion: Practice patterns indicate that chemical DVT prophylaxis initiated within 48 hours of
admission may be safe in patients with significant blunt hepatic trauma. Delays in prevention result
in venothromboembolic events, but not in fewer blood transfusions or a decreased need for
subsequent angiographic or operative therapies.
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Background
Hepatic trauma complicates 25% of all blunt injuries [1].
Modern management of these patients depends primarily
upon their hemodynamic stability and concurrent pattern
of injury. Recent series identify that 98% of all stable
patients, regardless of injury grade, can be successfully
managed without an operative procedure [2].
Deep venous thrombosis (DVT) is a common complica-
tion. The observed incidence among trauma patients
exceeds 50% when thromboprophylaxis is omitted [3].
Geerts and colleagues demonstrated that low molecular
weight heparins (LMWH) significantly reduce the inci-
dence of DVT compared to unfractionated heparin (UH),
with rates of 7% and 15% respectively [4]. As a result,
enoxaparin has become the standard pharmaceutical
agent for DVT prophylaxis in multisystem trauma
patients. In spite of its benefit, surgeons often delay the
initiation of chemical DVT prophylaxis in those with
blunt hepatic trauma due to the potential risk of recurrent
bleeding. When coupled with the pathophysiology of
multisystem injuries, which often include pelvic and head
trauma, this delay places patients at an increased risk for
DVT formation.
The optimal timing of DVT prophylaxis for blunt hepatic
injured patients is unclear. The purpose of this study was
to (1) identify the usage pattern of DVT prophylaxis in
non-operative patients with blunt hepatic injuries among
high volume trauma facilities, and (2) compare the out-
comes of patients with early versus delayed initiation of
chemical DVT prophylaxis.
Methods
A multi-institutional (University of Alberta and Foothills
hospitals), retrospective review of all patients with blunt
hepatic injuries occurring between October, 2000 and
October, 2004 was performed. The data was extracted
from the province-wide Alberta Trauma Registry (ATR).
This registry prospectively collects data on all patients sus-
taining a severe injury (Injury Severity Score (ISS) = 12)
within the province of Alberta. The ATR also possesses
detailed information describing the mechanism of injury,
patient injuries, all therapies, and inpatient outcomes.
This database has been internally validated to be 98%
accurate [5].
The ethics review committees at the Universities of Cal-
gary and Alberta approved the study protocol. Inclusion
criteria included patients with an ISS ≥ 12 and a computed
tomography (CT) scan confirming blunt hepatic injury.
Patients were excluded if they had a penetrating liver
injury, intracranial hemorrhage, or died within 24 hours
of admission. They were also excluded if they underwent
operative or angiographic intervention within 24 hours of
admission.
Two staff radiologists, experienced in trauma imaging,
completed blinded individual reviews of all patient CT
imaging. Hepatic injuries were re-graded using the Amer-
ican Association for the Surgery of Trauma liver injury
scale [6]. Both radiologists were blinded to the initial
admitting radiological interpretation. Patients were then
divided into three groups based on the timing of pharma-
cologic DVT prophylaxis. "Early" patients received DVT
prophylaxis within 48 hours; "delayed" patients received
prophylaxis after 48 hours; and the final group received
no DVT prophylaxis during their hospital admission.
DVTs were diagnosed by clinical suspicions confirmed by
ultrasound imaging. Pulmonary emboli (PE) were diag-
nosed via thoracic CT. All compression stockings were
sequential pneumatic devices. Study endpoints included
post-admission blood transfusions (packed red blood
cells (pRBC)), post-admission angiographic emboliza-
tion, non-operative failure, DVT formation, and the rate
of PE.
Statistical analysis was performed using Stata version 8.0
(Stata Corp. College Station, Texas, USA). Normally or
near-normally distributed variables were reported as
means and non-normally distributed variables as medi-
ans. Differences were demonstrated using ANOVA and
Student t-tests. A p value less than 0.05 was considered to
represent statistical significance for all comparisons.
Results
During the study period, 390 patients were diagnosed
with a hepatic injury. One hundred and six (27%) met the
study inclusion criteria (Table 1). No patients died. DVT
prophylaxis was administered in the early and delayed
cohorts in 25% (27/106) and 42% (45/106) respectively.
Thirty-four (32%) additional patients received no phar-
macologic DVT prophylaxis. Demographics and initial
hemodynamic measurements were similar between all
groups (Table 1). There was a higher rate of blood trans-
fusions in the delayed cohort (24%), compared to the
early and no DVT prophylaxis groups (11% and 12%
respectively)(p = 0.03). The mean ISS was also higher in
the delayed group when compared to the no prophylaxis
cohort (p = 0.02).
The mean hepatic injury grades were lower in the early
prophylaxis group (2.2) compared to either the delayed or
no prophylaxis cohorts (2.9 and 3 respectively) (p =
0.002). Most (70%) patients in the early group were com-
prised of lower grade injuries (I, II). The majority of
patients in the delayed group (78%) had higher injury
grades (III, IV, V) (Table 1). Post-admission hemoglobin
levels were stable across all cohorts (p = 0.47) (Table 2).
The mean hospital length of stay (LOS) was highest in the
delayed prophylaxis group (26 days), followed by the
early and no prophylaxis groups (14 and 8 days respec-
tively)(p = 0.0003) (Table 2). The delayed group also pos-Journal of Trauma Management & Outcomes 2009, 3:7 http://www.traumamanagement.org/content/3/1/7
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sessed the highest rate of ICU admission (44%), with an
associated mean LOS of 9 days, while the no prophylaxis
cohort required ICU care in only 9% of patients. Pharma-
cologic DVT prophylaxis was most commonly initiated on
post admission day 1 for the early group and day 6 for the
delayed group (Table 2). LMWH was used in 78% of
patients in the early group and 84% of patients in the
delayed cohort. UH was employed in the remainder.
Overall, the delayed group experienced the highest rate of
post-admission blood transfusions (44%) when com-
pared to both the early and no prophylaxis groups (26%
and 6% respectively)(Table 3). There were no delayed
arterial embolizations or non-operative management fail-
ures in the early and no prophylaxis groups. In the
delayed prophylaxis group however, 2 patients failed non-
operative observation. Both suffered grade 5 injuries. One
of these patients also underwent pre-operative arterial
embolization. No DVT or PE was diagnosed in the early or
no prophylaxis groups. Eight (18%) patients were diag-
nosed with a DVT in the delayed group, with one (2%)
patient developing a clinically significant PE.
The early and delayed prophylaxis groups were also delin-
eated based on grade of injury (Table 4 and Table 5).
There was no increase in the rates of post-admission
blood transfusion, arterial embolization, or non-opera-
tive failure in patients with low grade (Grade I and II)
injuries who received early pharmacologic DVT prophy-
laxis. There was however, 1 DVT (10%) diagnosed in a
Table 1: Patient demographics and injuries
Variable Early Delayed None
Total 27 45 34
Mean Age 37 42 30
Gender (% male) 63 78 59
Mean ISS 22 25 20
Mean Number of Injuries 7 9 5
Mean Admission Blood Pressure 130 124 128
Mean Admission Heart Rate 93 97 89
Blood Transfusion (%) 11 22 12
Mean Number of Blood Units 2 3 2.5
Mean Admission Hemoglobin 127 121 126
Hepatic Injury Grade:
Mean 2.2 2.9 3.0
Grade 1 6/27 (22%) 6/45 (13%) 1/34 (3%)
Grade 2 13/27 (48%) 4/45 (9%) 9/34 (25%)
Grade 3 5/27 (19%) 24/45 (54%) 14/34 (42%)
Grade 4 3/27 (11%) 9/45 (20%) 9/34 (26%)
Grade 5 0 2/45 (4%) 1/34 (3%)
ISS = Injury Severity Score
Table 2: Inpatient demographics
Variable Early Delayed None
Total 27 45 34
Mean Hemoglobin (PAD 2) 109 98 118
Mean Hemoglobin (PAD 5) 104 105 116
Mean Length of Hospital Stay (days) 14 26 8
ICU Admission (%) 22 44 9
Mean length of ICU Stay (days) 8 9 3
Mean PAD Ambulation Allowed 3 6 4
Use of Compression Stockings (%) 44 91 71
Mean PAD DVT Prophylaxis Started 1 6 -
LMWH (%) 78 84 -
Unfractionated Heparin (%) 22 16 -
PAD = Post Admission Day
ICU = Intensive Care Unit
DVT = Deep Venous Thrombosis
LMWH = Low Molecular Weight Heparin
Table 3: Patient outcomes
Variable Early Delayed None
Total 27 45 34
Blood Transfusion Post-Admission(%) 26 44 6
Mean Number of Blood Units 2.6 4.3 1.5
Arterial Embolization (%) 0 2 0
Failure of Non-operative Therapy(%) 0 4 0
Deep Venous Thrombosis (%) 0 8/45 (18) 0
LMWH Group (%) 0 4/8 (50) 0
Pulmonary Embolus (%) 0 1/45 (2) 0
LMWH Group (%) 0 0/1 (0) 0
LMWH = Low Molecular Weight HeparinJournal of Trauma Management & Outcomes 2009, 3:7 http://www.traumamanagement.org/content/3/1/7
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patient with a low grade injury with delayed DVT proph-
ylaxis. Although the ISS (p = 0.53) and mean number of
injuries (p = 0.26) were similar between both cohorts, the
delayed group had a higher ICU admission rate (60% ver-
sus 16% respectively), and hospital LOS (24 versus 11
days respectively) (p = 0.0069).
In patients with high grade hepatic injuries, only 8
received early pharmacologic DVT prophylaxis (Table 5).
These groups had a similar ISS (p = 0.90) and mean
number of injuries (p = 0.13). The ICU admission rate
and hospital LOS were also similar between the early and
delayed groups (p = 0.71). Two patients (grade 5 injuries)
failed non-operative observation. Overall 8 (18%) DVTs
and 1 (2%) PE were diagnosed in patients who had a
delay in pharmacologic DVT prophylaxis.
Discussion
Multi-system trauma is a major risk factor for the develop-
ment of a DVT. In patients without thromboprophylaxis,
the overall incidence exceeds 50% and the rate of proxi-
mal limb DVTs approaches 18% [3,7,8]. Although an iso-
lated DVT is rarely life-threatening, subsequent PE often
carry significant morbidity and mortality. Pulmonary
embolism is estimated to be the third leading cause of
death in trauma patients who survive beyond the first day
[3,9-11]. While non-operative management of hepatic
trauma appears to be safe in up to 98% of hemodynami-
cally stable patients, the optimal timing of pharmacologic
DVT prophylaxis is unclear [2]. There is often a delay in
the administration of chemical prophylaxis in an attempt
to prevent recurrent liver hemorrhage, and therefore the
perceived risk of converting non-operative candidates into
operative cases. As a result, physicians must balance the
risk of re-bleeding with the development of a venous
thromboembolism.
In this study population, only 2 patients failed non-oper-
ative observation. Both had grade 5 hepatic injuries that
hemorrhaged prior to initiating DVT prophylaxis. As
expected, patients with lower grade injuries were more
likely to receive early prophylaxis compared to those with
high grade hepatic injuries. Approximately 80% of
patients with high grade injuries received delayed DVT
prophylaxis. Considering the rare occurrence of non-oper-
ative treatment failure, this difference is particularly strik-
ing because only 34% of patients with low grade injuries
were delayed in their chemical prophylaxis.
A significant subset of patients (33%) received no phar-
macologic DVT prophylaxis. This group possessed a mean
hepatic injury grade that was nearly identical to the
delayed prophylaxis cohort (3 versus 2.9 respectively).
They did however have a significantly shorter hospital
LOS (8 versus 26 days respectively). The most likely expla-
nation for the lack of prophylaxis in this group was that
these patients were expected to receive 'delayed' prophy-
laxis but were discharged before chemical prevention was
initiated. We view this as a treatment failure by our
trauma services. These patients displayed no clinically sig-
nificant DVTs or PEs during their hospital admission. We
believe this is a direct result of their early ambulation.
Because outpatient follow-up data was not available, the
actual number of patients in any particular group who
were discharged home and later developed a DVT or PE is
unknown.
Neither failure in non-operative observation, nor
increases in blood transfusions were observed in patients
who received early DVT prophylaxis. Although limited
patient numbers and an injury grade bias across study
groups made it difficult to draw definitive conclusions,
Table 4: Comparison of early and delayed prophylaxis group 
outcomes for grade 1 and 2 hepatic injuries
Variable Early Delayed
Total 19 10
Mean ISS 21 22
Mean Length of Hospital Stay (days) 11 24
ICU Admission (%) 16 60
Mean PAD DVT Prophylaxis Started 1 6
Blood Transfusion Post-Admission(%) 26 40
Mean Number of Blood Units 2.6 4
Arterial Embolization (%) 0 0
Failure of Non-operative Therapy(%) 0 0
Deep Venous Thrombosis (%) 0 1/10 (10)
Pulmonary Embolus (%) 0 0
ISS = Injury Severity Score
ICU = Intensive Care Unit
PAD = Post Admission Day
DVT = Deep Venous Thrombosis
Table 5: Comparison of early and delayed prophylaxis group 
outcomes for grades 3, 4 and 5 hepatic injuries
Variable Early Delayed
Total 8 35
Mean ISS 26 25
Mean Length of Hospital Stay (days) 23 27
ICU Admission (%) 38 37
Mean PAD DVT Prophylaxis Started 1 6
Blood Transfusion Post-Admission(%) 25 46
Mean Number of Blood Units 2 4
Arterial Embolization (%) 0 3
Failure of Non-operative Therapy(%) 0 6
Deep Venous Thrombosis (%) 0 7/35 (20)
Pulmonary Embolus (%) 0 1/35 (3)
ISS = Injury Severity Score
ICU = Intensive Care Unit
PAD = Post Admission Day
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this study suggests that early pharmacologic DVT prophy-
laxis may be safe in patients with blunt liver trauma. This
cannot be confirmed elsewhere in the literature because
the only publication to describe a comparable patient
population did not assess the use or timing of pharmaco-
logic DVT prophylaxis [2]. It did appear that the majority
of their patients who failed non-operative therapy had
grade 4 and 5 injuries however [2]. It is also important to
note that had our study employed prospective ultrasound
screening for all trauma patients (rather than screening for
those patients with a "high" clinical suspicion for DVT),
the rates of DVT in the delayed and no prophylaxis
cohorts may have been even more substantial.
Conclusion
In summary, 98% of our patients underwent successful
non-operative management of blunt hepatic injuries.
Patients with low grade injuries generally received phar-
macologic DVT prophylaxis early in their hospital admis-
sion. Most importantly, early pharmacologic DVT
prophylaxis did not result in increased blood transfusion
requirements or non-operative failures. This was consist-
ent regardless of the injury grade. As a result of this data,
we are now beginning to standardize early prophylaxis in
our patients with blunt hepatic trauma. We believe that
delays in pharmaceutical prevention place patients at a
significantly increased risk for venothromboembolic
events. This risk approximates 18% if prophylaxis is
delayed more than 48 hours after admission. To confirm
these observations, a multicenter randomized controlled
trial is planned.
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